Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not affect the pharmacokinetics of ethinyl estradiol or norethindrone in healthy female subjects - Migoya_2011_J.Clin.Pharmacol_51_1319 |
| Author(s) : Migoya E , Larson P , Bergman A , Miller J , Johnson-Levonas AO , Lasseter KC , Wagner JA |
| Ref : Journal of Clinical Pharmacology , 51 :1319 , 2011 |
| Abstract : Migoya_2011_J.Clin.Pharmacol_51_1319 |
| ESTHER : Migoya_2011_J.Clin.Pharmacol_51_1319 |
| PubMedSearch : Migoya_2011_J.Clin.Pharmacol_51_1319 |
| PubMedID: 21209231 |
| Title : Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension - Mistry_2008_J.Clin.Pharmacol_48_592 |
| Author(s) : Mistry GC , Maes AL , Lasseter KC , Davies MJ , Gottesdiener KM , Wagner JA , Herman GA |
| Ref : Journal of Clinical Pharmacology , 48 :592 , 2008 |
| Abstract : Mistry_2008_J.Clin.Pharmacol_48_592 |
| ESTHER : Mistry_2008_J.Clin.Pharmacol_48_592 |
| PubMedSearch : Mistry_2008_J.Clin.Pharmacol_48_592 |
| PubMedID: 18353996 |
| Title : The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin - He_2007_Eur.J.Clin.Pharmacol_63_677 |
| Author(s) : He YL , Sabo R , Campestrini J , Wang Y , Ligueros-Saylan M , Lasseter KC , Dilzer SC , Howard D , Dole WP |
| Ref : European Journal of Clinical Pharmacology , 63 :677 , 2007 |
| Abstract : He_2007_Eur.J.Clin.Pharmacol_63_677 |
| ESTHER : He_2007_Eur.J.Clin.Pharmacol_63_677 |
| PubMedSearch : He_2007_Eur.J.Clin.Pharmacol_63_677 |
| PubMedID: 17486328 |
| Title : Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes - Herman_2006_J.Clin.Endocrinol.Metab_91_4612 |
| Author(s) : Herman GA , Bergman A , Stevens C , Kotey P , Yi B , Zhao P , Dietrich B , Golor G , Schrodter A , Keymeulen B , Lasseter KC , Kipnes MS , Snyder K , Hilliard D , Tanen M , Cilissen C , De Smet M , De Lepeleire I , Van Dyck K , Wang AQ , Zeng W , Davies MJ , Tanaka W , Holst JJ , Deacon CF , Gottesdiener KM , Wagner JA |
| Ref : J Clinical Endocrinology Metab , 91 :4612 , 2006 |
| Abstract : Herman_2006_J.Clin.Endocrinol.Metab_91_4612 |
| ESTHER : Herman_2006_J.Clin.Endocrinol.Metab_91_4612 |
| PubMedSearch : Herman_2006_J.Clin.Endocrinol.Metab_91_4612 |
| PubMedID: 16912128 |
| Title : Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans - Marino_1998_J.Clin.Pharmacol_38_227 |
| Author(s) : Marino MT , Schuster BG , Brueckner RP , Lin E , Kaminskis A , Lasseter KC |
| Ref : Journal of Clinical Pharmacology , 38 :227 , 1998 |
| Abstract : Marino_1998_J.Clin.Pharmacol_38_227 |
| ESTHER : Marino_1998_J.Clin.Pharmacol_38_227 |
| PubMedSearch : Marino_1998_J.Clin.Pharmacol_38_227 |
| PubMedID: 9549661 |